A CLINICAL TRIAL TO STUDY THE EFFECT OF SHATAVARI GRANULES IN ACIDITY

An open label double arm randomized controlled clinical study to evaluate the efficacy of Shatavari granules in the management of Amlapitta (Non ulcer dyspepsia).

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/01/030237

Enrollment

Registered

2021-01-05

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K30- Functional dyspepsia

Interventions

Intervention1: SHATAVARI GRANULE: SHATAVARI CHURNA ia an ayurvedic medicine mention in ayurvedya pharmacopia of india(API) Volume 4 page no.122-123. SHATAVARI GRANULES it contains SHATAVARI CHURNA, SH

Eligibility

Inclusion criteria

Inclusion criteria: Patients having symptoms of Amlapitta like Avipaka, Klama, Utklesha, Tikta-amlauadgara, Hridakanthadaha, Gauvrava and Aruchi. - Chronicity not more than 1 year.

Exclusion criteria

Exclusion criteria: - Chronicity more than 1 year. - K/C/O Hypertension and Dibetes. - K/C/O Peptic ulcer, Duodenal ulcer, Malignancy. - Symptoms like Hematemesis & Malena. - Pregnant & lactating women.

Design outcomes

Primary

Measure	Time frame
Effect on symptoms of amlapittaTimepoint: Effect on symptoms of amlapitta at baseline and at the end of 7 days till 15 days	—

Secondary

Measure	Time frame
Symptoms like Avipaka Klama Utklesh Tikta-amlauadgar Hridakanthadaha Aruchi GauvravaTimepoint: effect on symptoms at baseline and at the end of 7 days and 15 days.	—

Countries

India

Contacts

Public ContactDr Tarangnaben Roshanbhai Gamit

Parul Institute of Ayurved

gamittarangna1677@gmail.com9978048889

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026